HI
SVA

Harbour Investments’s Sinovac Biotech, Ltd SVA Stock Holding History

Harbour Investments’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$542 Buy
+83
New +$542 ﹤0.01% 4237
2021
Q4 		– Sell
-180
Closed -$1K – 4062
2021
Q3 		$1K Hold
180
– – ﹤0.01% 3692
2021
Q2 		$1K Hold
180
– – ﹤0.01% 3735
2021
Q1 		$1K Buy
+180
New +$1K ﹤0.01% 3572

Other funds holding SVA

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
NAH
Neumann Advisory (HK) Central, Hong Kong $356M AUM 37.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HI
Horizon Investments Charlotte, North Carolina $8.92B AUM 25.62% 1-Year Est. Return

Harbour Investments's SVA Position: Q1 2026 in Review

Harbour Investments opened a new position in Sinovac Biotech, Ltd (SVA) in Q1 2026: 83 shares worth $542. The stake represents ﹤0.01% of the portfolio and ranks #4237 among its holdings. This is a return to the name: Harbour Investments previously reported a position in SVA as recently as Q3 2021.

Harbour Investments first reported a position in SVA in Q1 2021 and has held it in 4 quarters since. The position peaked at $1K in Q3 2021. 28 funds tracked by Wall St. Rank hold SVA as of Q1 2026.

  • Harbour Investments held 83 shares of Sinovac Biotech, Ltd worth $542 as of Q1 2026.
  • Sinovac Biotech, Ltd was a new Harbour Investments position in Q1 2026.
  • Sinovac Biotech, Ltd made up ﹤0.01% of Harbour Investments's portfolio in Q1 2026, its #4237 holding.
  • Harbour Investments first reported a position in Sinovac Biotech, Ltd in Q1 2021 and has held it in 4 quarters since.
  • Harbour Investments's Sinovac Biotech, Ltd position peaked at $1K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.